Related Experiment Video
Updated: Sep 25, 2025
07:25
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
8.7K
A Historical Perspective on the Dopamine D3 Receptor.
Pierre Sokoloff1, Bernard Le Foll2,3,4,5,6,7,8
1Biodol Therapeutics, Clapiers, France.
Current Topics in Behavioral Neurosciences
|April 25, 2022
Summary
The D3 dopamine receptor, initially controversial, was identified using molecular biology. Selective compounds confirmed its role in motor function, addiction, cognition, and schizophrenia, aiding new psychiatric drug development.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Dopamine receptor research was limited to D1 and D2 subtypes before 1990.
- Antipsychotic efficacy was primarily attributed to D2 receptor blockade.
- The existence of additional dopamine receptor subtypes was debated.
Purpose of the Study:
- To characterize the D3 dopamine receptor as a distinct molecular entity.
- To investigate the potential functions of the D3 receptor in behavior.
- To develop selective compounds for D3 receptor research.
Main Methods:
- Utilized molecular biology techniques for receptor characterization.
- Synthesized and tested D3-selective compounds in vitro and in vivo.
- Examined the anatomical gene expression and signaling pathways of the D3 receptor.
Main Results:
- The D3 receptor was identified as a distinct molecular entity with unique gene expression and signaling.
- Development of potent and selective D3 receptor ligands was achieved.
- D3 receptor involvement was confirmed in motor functions, addiction, cognition, and schizophrenia.
Conclusions:
- The D3 receptor plays significant roles in various neurological and psychiatric processes.
- Selective D3 receptor modulators hold promise for treating psychiatric disorders.
- Further research into D3 receptor pharmacology can lead to novel therapeutic strategies.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
01:21Antipsychotic Drugs: Typical and Atypical Agents
369
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
369
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.1K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.1K
01:22Opioid Receptors: Overview
2.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.1K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
760
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
760
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K